High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.
Brieger KK, Phung MT, Mukherjee B, Bakulski KM, Anton-Culver H, Bandera EV, Bowtell DDL, Cramer DW, DeFazio A, Doherty JA, Fereday S, Fortner RT, Gentry-Maharaj A, Goode EL, Goodman MT, Harris HR, Matsuo K, Menon U, Modugno F, Moysich KB, Qin B, Ramus SJ, Risch HA, Rossing MA, Schildkraut JM, Trabert B, Vierkant RA, Winham SJ, Wentzensen N, Wu AH, Ziogas A, Khoja L, Cho KR, McLean K, Richardson J, Grout B, Chase A, Deurloo CM, Odunsi K, Nelson BH, Brenton JD, Terry KL, Pharoah PDP, Berchuck A, Hanley GE, Webb PM, Pike MC, Pearce CL; Ovarian Cancer Association Consortium.
Brieger KK, et al. Among authors: khoja l.
Cancer Epidemiol Biomarkers Prev. 2022 Feb;31(2):443-452. doi: 10.1158/1055-9965.EPI-21-0977. Epub 2021 Nov 17.
Cancer Epidemiol Biomarkers Prev. 2022.
PMID: 34789471
Free PMC article.